NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical trial, a pretzel-shaped device that slowly releases chemotherapy drugs ...

The FDA granted the PD-L1 inhibitor Tecentriq an accelerated approval in May 2016 as a treatment for patients with locally advanced or metastatic urothelial carcinoma, following encouraging results of ...

In May, researchers reported something that would have sounded like science fiction a generation ago. In patients with ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

Patients with early bladder cancer who have gone 5 years without relapse may be considered “cured,” researchers suggested. In considering outcomes for evaluating how “cure” is defined in early bladder ...

An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland. Dr. Heather Chalfin, a urologic ...

Researchers are giving us new insights into early detection and treatments, but with access to life-saving care remaining uneven patients still have a long road ahead ...

A major clinical trial led by Tata Memorial Hospital (TMH), Mumbai, and conducted across four Indian cancer centres over eight years has found that radiation therapy after bladder removal surgery can ...

(NewsNation) — NewsNation anchor Chris Cuomo hosted a live national conversation examining why cancer remains incurable despite billions in research funding. Guests on the special included top ...